Professional journals serve as critical avenues to promote communication of new research findings and syntheses of scientific information throughout the medical community. There can be a delay, however, in the application of such scientific information to actual clinical practice. In the field of integrative cancer care, this normal delay is complicated by the implementation of many techniques of alternative, complementary, and traditional medicine before scientific validation. Both of these patterns can leave the practitioner scrambling to understand new trends in the field. To begin to address the problem of advancing clinical practice and understanding in integrative cancer care, this journal is offering an article series that we call the Integrative Tumor Board.
The Integrative Tumor Board in Integrative Cancer Therapies is a forum unique among journal-based tumor boards. It is modeled on the activities of a hospital tumor board but is based on an integrative cancer medicine perspective. In typical tumor boards, a physician will present standard clinical data on a case, and several medical specialists will then comment on the case from their own perspectives. The unique feature of the Integrative Tumor Board is that in addition to comments from medical specialists, practitioners of a variety of complementary, alternative, and integrative disciplines will also give their analyses of each case. Final comments will be made at the end of the practitioner contributions, pointing out particularly interesting features or raising issues or concerns; comments are supervised by the journal's editor-in-chief in consultation with experts in several relevant disciplines. Integrative Tumor Boards will be presented in most or all issues of Integrative Cancer Therapies; they will be composed of recommendations of rotating panels of medical specialists and other practitioners.
It is important that the reader understand some of the basic premises of the Integrative Tumor Board: Board articles should not be construed as endorsements of these interventions by the journal's editorial staff or members of any of its editorial boards. We do not expect readers to agree with all Tumor Board recommendations. Specific problem areas in Tumor Board suggestions will be noted in the comments, especially in areas that might pose potential risks; we will not, however, discuss every area of disagreement. 2. Recommendations in the Integrative Tumor Board are not presented as an example of how patients should be treated from an integrative medicine perspective. Actual treatment at an integrative clinic requires regular interaction and exchange among the cooperating practitioners and overall supervision by a physician who is aware of the potential contributions of the various disciplines represented in the clinic. The Integrative Tumor Board is, rather, a venue to present perspectives of a variety of disciplines important in integrative cancer care in a public forum. Its purpose is to promote knowledge and understanding of these perspectives by all health professionals working with cancer patients, since the majority of cancer patients currently are taking advantage of 1 or more integrative therapies. We will try to encourage important areas of synergy and point out potential negative interactions (e.g., drug-herb interactions), recognizing that adequate management of both is fundamental to truly integrative care. However, this is not easily accomplished when practiced within a single facility, let alone when bringing together many modalities from several different practitioners. Still, we will attempt to address as best we can the more relevant interrelationships.
Not all of the suggestions made in Integrative Tumor
Board articles will be solidly evidence based, particularly since some aspects of integrative care fall into a category one might call intangibles. Still, we are encouraging integrative practitioners to make an attempt to anchor suggestions in scientific evidence, or at least to submit suggestions that are not unreasonable from a scientific or psychological viewpoint, or from a traditional medicine perspective in the articles submitted by practitioners from various schools of traditional medicine. 4. We expect that the many evidence-based or scientifically reasonable suggestions in Integrative Tumor Board articles will be viewed with seriousness even by readers accustomed to working in a conventional medicine perspective. Such readers may be startled, however, by some of the less evidence based suggestions, or by the spiritual counseling that will be offered by some practitioners. Conventionally oriented health professionals should realize that their cancer patients may indeed be seeing practitioners who work from less evidence-based perspectives. We strongly feel both that this is a relevant aspect of integrative care and that it is important that health professionals understand the nature of such perspectives, and some of the potentially healthful (or unhealthful) practices they prescribe. This is essential information for those electing to work constructively with patients who are using practices of alternative, complementary, and traditional medicine in coping with their illnesses. 5. As will become evident in the Case Presentation, the information given to contributing practitioners is the clinical data obtained before counseling the patient on an integrative intervention. The initial case also may include information on lifestyle and psychosocial issues of the patient taken from a comprehensive questionnaire administered at the clinic of the presenting physician; details of some of this information from the actual patient, or the clinical information, may be changed to enable a clearer and more focused discussion or to promote elaboration of certain issues. Many laboratory analyses, and all traditional medicine diagnostic techniques, are absent from the presentation. This limits the ability of practitioners to make specific recommendations for the patient, as several have noted. In response, however, most of the practitioners have made their own recommendations for laboratory analyses and other diagnostic techniques. In these recommendations, one can perceive the types of clinical analysis used in each discipline included in the Integrative Tumor Boardinformation that is surely as useful as specific clinical suggestions in developing an understanding of integrative approaches to cancer.
Many readers will find the volume of information included in the Tumor Board articles overwhelming. This reaction is, in fact, typical of those attending hospital tumor boards as well. We also feel that it is true that integrative care itself can seem overwhelming to both practitioners and patients, particularly those just beginning their encounters with the field. This is not an irrelevant issue when working with patients already facing circumstances surrounding their illness and treatments that are burdensome in and of themselves. As we have found in patient care, and as we trust will occur with those of you new to integrative cancer treatment, you will become more familiar with the various practices that will be included in the Integrative Tumor Board, and this sense of being submerged in information will diminish. We hope that the Tumor Board series will advance comprehension of both the conventional medical interventions and the complementary, alternative, and traditional medicine interventions on the part of health professionals and patients as this new approach to cancer care grows and develops. In October 2001, lumbosacral spine x-ray for lower back pain noted degenerative joint disease at L2 and L3 and mild anterior wedging to T12. A subsequent bone scan was negative for any evidence of bony metastasis. The patient had a needle biopsy of the right-midlung lesion that showed scant cellularity and no tumor cells. She was advised to have a further biopsy in November, but canceled it. In December 2001, her physician ordered a chest x-ray, which revealed a pulmonary nodule in the right-middle lung field. CT scan confirmed a spiculated nodular infiltrative density adjacent to the aortic arch. Extensive fatty infiltration of the liver was observed, along with a 1.5 cm nodule in the right adrenal gland. Bronchoscopy was inconclusive. The patient was seen at the Block Center for Integrative Cancer Care in January 2002, for a full evaluation. A CT scan in February showed a spiculated mass in the right-upper lobe and a small spiculated density at the right apex; the right adrenal mass was also seen. She was sent for lung biopsy of the right-upper-lobe spiculated mass; the diagnosis was poorly differentiated adenocarcinoma. A positron emission tomography (PET) scan was done in March that showed increased uptake of the rightupper-lobe lung mass but no increased uptake in the adrenal. After the PET scan, the patient consulted with a thoracic surgeon, who then did a right upper lobectomy and mediastinal node biopsies. Final pathology report revealed 11 nodes positive for metastatic adenocarcinoma, with none of the mediastinal nodes found to be positive for metastatic disease. No distant metastases were found by CT or bone scan. The patient was classified as having stage IIA lung cancer. The patient was discharged in fair condition from the hospital.
Recently Diagnosed Lung Cancer

Past medical history:
Occasional irregular heartbeat since her mid 20s, cardiac evaluation was negative; history of carpal tunnel syndrome; history of Von Willebrand disease.
Past surgical history: Angiogram and ileofemoral embolectomy in 1973; abdominal hysterectomy for fibroids in 1978.
Menstrual history: Menarche at age 13; last menstrual period was at age 33 due to hysterectomy; no history of hormone replacement therapy; last Pap smear [in 1998 ] was within normal limits; last mammogram [in 1999] was within normal limits.
Family history: Father died at age 78 due to an unknown type of cancer; mother died at age 80 due to a myocardial infarction. Two sisters, ages 58 and 56, alive and well; 3 brothers, ages 63, 54, and 50, the youngest with a history of myocardial infarction. Two aunts and a grandmother died of unknown cancers.
Social history: Retired nurse. Divorced. Has always been active in local politics; reports having experienced substantial stress from local political campaigns in which she participated in her early 40s. Smokes about a pack a day of cigarettes for the past 40 years; continues to smoke at intake. Has binges of heavy alcoholic intake, about 4 to 6 glasses of wine per day; is characterized as alcohol dependent in evaluation by a university hospital.
Allergies: None.
Medications: None.
Supplement history: None.
Exercise history: Does not exercise now but reports that in the past her exercise activities have included dancing, swimming, walking, and gardening. Active in square-dancing with her former husband prior to age 40.
Review of systems:
General: 15 to 20 lb weight loss over the past 8 to 12 months. Cardiorespiratory: hoarseness since October 2001. Is allergic to pollen. Experiences dyspnea on exertion and stair climbing. Gastrointestinal: normal. Genitourinary: normal. Neurologic: normal. Psychiatric: history of panic attacks and anxiety. Denies depression or suicidal ideation.
Physical exam:
Vital signs: blood pressure 140/80; pulse rate 76; weight 169 lb; height 5′4″. Head/eyes/ears/nose/throat: pupils equal, round, reactive to light and accommodation, sclera anicteric. Orophar ynx: tongue shows mild glossitis and scaphoiding, white coating on surface of tongue. Neck: supple with no palpable adenopathy. Supraclavicular nodes normal. Chest: symmetrical in contour. Lungs positive for rhonchi at the bases; occasional end expiratory wheezing at the apex on the right lung. Cardiovascular: regular rate and rhythm, no murmurs, S1 and S2 within normal limits, no S3 or S4. Abdomen: obese, soft, nontender, no palpable hepatosplenomegaly. Neurologic: no focal deficits. Extremities: no clubbing, cyanosis, or edema.
Abnormal or significant laboratory results (January 2002)
: aspartate amino transferase: high (61); alanine amino transferase: high (54); bilirubin: normal (0.3 md/dL); bleeding time: normal (5 seconds); red blood cell distribution width: high (14.7%); partial thrombin time: high (35.8 seconds); prothrombin time: normal (11.5 seconds); international normalized ratio: normal (1.0); Von Willebrand factor: high (160%); Von Willebrand factor antigen: normal (101%); factor VIII: normal (143%); platelet adhesiveness: low (52%); aggregation from adenosine diphosphate, ristocetin, collagen, arachidonic acid, and epinephrine: normal; alkaline phosphatase: normal (80 IU/L).
Dietary history:
Was born in England. Has always eaten an American-type diet. Currently eats 2 meals per day, 90% of meals at home, using gas for cooking. She describes her appetite as fair to good. She sometimes craves potatoes, and likes sweet and sour flavors. Food intolerances are coffee, apples, bananas, oranges, strawberries, pecans, cashews, walnuts, pork, beets, tomatoes, beans, perch, and halibut. She experiences hoarseness and loss of hearing on ingesting these foods. One-day diet (before integrative nutrition intervention): breakfast, eggs and bacon; dinner, chicken; beverages: water.
Environmental exposures: Is an apartment building manager for 3 small buildings in a suburban area; is exposed to paint and cleaning materials.
Musculoskeletal issues: Reports back pain; report of evaluation by university physician mentions osteoarthritis involving lumbosacral spine.
Life patterns:
Lived in a bomb shelter as a child in England during World War II. Has been through an amicable divorce, but present intimate relationship situation is rocky. She volunteers at an animal shelter on a weekly basis. She describes herself as warm, affectionate, and trusting. She is self-reliant but needs to be with people. In general, her relationships with people are very good to excellent. She would like to be more spiritual. Activities for relaxation include reading, walking, gardening, playing cards, painting, and socializing with friends. Maintains substantial interest in politics but is no longer active. Lives in Ohio, travels to Block Center by car for consultations. 
Medical Oncology Analysis
Cancer of the lung remains a major contributor to cancer mortality in the United States. The death rates in men have decreased slightly in the past few years, most likely related to a significant reduction in the percentage of men who smoke. Unfortunately, the death rates in women are still rising due to a more gradual decrease in smoking by women. The case presented in this Integrative Tumor Board is an example of an individual who is severely addicted to cigarettes and who, even in the face of a diagnosed cancer of the lung, cannot give up smoking. Any of the treatment plans presented for this case should focus on the need to help this patient control her addiction using several treatment modalities. I support this approach, and because I have had personal experience in coleading mind/body programs for cancer patients, I have seen the beneficial effects of such programs.
Diagnostic Workup
With regard to the medical oncology aspects of this case, the patient was diagnosed with a non-small-cell carcinoma of the lung (NSCLC), more specifically an adenocarcinoma of the lung, by needle biopsy of a small right-upper-lobe nodule. She underwent a CT scan of the chest and abdomen, a bone scan, and a PET scan to identify possible sites of metastases. The CT scan of the abdomen revealed a 2 cm lesion in the right adrenal, but the PET scan was negative in this area, and it was assumed that the adrenal mass was benign. Bone scan was negative for metastatic disease, and the CT scan and PET scan did not reveal mediastinal disease. However, no mediastinoscopy was carried out. Because the patient did not have definite evidence of distant metastases, she underwent a rightupper lobectomy and was found to have a primary adenocarcinoma of the lung measuring 1.8 × 1.5 × 1.3 cm. Eleven nodes were positive for metastases, but no biopsied mediastinal nodes were positive. She was classified as having stage IIA NSCLC. The patient had a rather comprehensive diagnostic workup preoperatively. Several additional studies would have been helpful in defining the extent of disease preoperatively. Magnetic resonance imaging (MRI) of the right adrenal mass would have been helpful in better defining the nature of this mass. The fact that the PET scan was negative in the area does not rule out malignancy, since there is at least a 10% rate of false-positive and false-negative results. If the MRI results were not definitive in ruling out metastasis, a needle biopsy of the adrenal mass would be indicated. Mediastinoscopy can also be very helpful preoperatively in diagnosing the operability and extent of disease in carcinoma of the lung. 1 This procedure would have added to the accuracy of the staging of the patient's disease.
Therapeutic Approaches
Surgery is the usual form of treatment in patients with stage IIA lung cancer. Adjuvant chemotherapy or radiation therapy does not significantly improve outcome
